UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000053367
Receipt number R000060905
Scientific Title Effects of simultaneous intake of water-soluble liquid konjac and indigestible dextrin on gut microbiota composition in young women: an open-label, cross-over, before-after comparison, dose-dependent study
Date of disclosure of the study information 2024/01/16
Last modified on 2024/07/16 11:37:56

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effects of simultaneous intake of water-soluble liquid konjac and indigestible dextrin on gut microbiota composition in young women: an open-label, cross-over, before-after comparison, dose-dependent study

Acronym

Effects of simultaneous intake of water-soluble liquid konjac and indigestible dextrin on gut microbiota composition in young women: an open-label, cross-over, before-after comparison, dose-dependent study

Scientific Title

Effects of simultaneous intake of water-soluble liquid konjac and indigestible dextrin on gut microbiota composition in young women: an open-label, cross-over, before-after comparison, dose-dependent study

Scientific Title:Acronym

Effects of simultaneous intake of water-soluble liquid konjac and indigestible dextrin on gut microbiota composition in young women: an open-label, cross-over, before-after comparison, dose-dependent study

Region

Japan


Condition

Condition

Healthy adults

Classification by specialty

Not applicable Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate changes in human gut microbiota composition with continuous intake of test substances.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Changes in human gut microbiota with continuous intake of test substances.

Key secondary outcomes

1. Subjective defecation status.
2. Body weight.


Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Dose comparison

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Food

Interventions/Control_1

Duration: 4 weeks.
Test substance: water-soluble liquid konjac and indigestible dextrin-containing food (120 g/1 bag).
Administration: 1 time/day.

Interventions/Control_2

Duration: 4 weeks.
Test substance: water-soluble liquid konjac and indigestible dextrin-containing food (120 g/1 bag).
Administration: 2 time/day.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

35 years-old >

Gender

Female

Key inclusion criteria

Healthy adults

Key exclusion criteria

1. Food allergy (especially konjac).
2. Took antibiotics within 3 weeks of the start of this study.
3. Regularly use laxatives.
4. Diseases of the large intestine, prone to diarrhea and other gastrointestinal diseases.
5. Having or history of chronic diseases as follows, malignant tumor, heart failure, or myocardial infarction.
6. Having or history of chronic diseases as follows, cardiac arrhythmia, liver disorder, kidney disorder, cerebrovascular disorder, rheumatism, diabetes mellitus, dyslipidemia, hypertension, or any other chronic diseases.
7. Pregnant, lactating, or planning to become pregnant during this trial.
8. Participate in other clinical studies or participated in the last 28 days or plan to participate in other clinical studies.
9. Smoker.
10. BMI>30.0 or BMI<17.0.

Target sample size

25


Research contact person

Name of lead principal investigator

1st name Misaki
Middle name
Last name Kurawaka

Organization

Jumonji University

Division name

Department of Food Science, Faculty of Human Life

Zip code

352-8510

Address

2-1-28 Sugasawa, Niiza, Saitama, 352-8510, Japan

TEL

048-477-0555

Email

m-krwk@jumonji-u.ac.jp


Public contact

Name of contact person

1st name Misaki
Middle name
Last name Kurawaka

Organization

Jumonji University

Division name

Department of Food Science, Faculty of Human Life

Zip code

352-8510

Address

2-1-28 Sugasawa, Niiza, Saitama, 352-8510, Japan

TEL

048-477-0555

Homepage URL


Email

m-krwk@jumonji-u.ac.jp


Sponsor or person

Institute

Jumonji University

Institute

Department

Personal name



Funding Source

Organization

Konnyakuya-Honpo Co., Ltd.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Research Ethics Committee, Jumonji University

Address

2-1-28 Sugasawa, Niiza, Saitama, 352-8510, Japan

Tel

048-477-0555

Email

k-kenkyu@jumonji-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

十文字学園女子大学(埼玉県)、一般財団法人辨野腸内フローラ研究所(埼玉県)


Other administrative information

Date of disclosure of the study information

2024 Year 01 Month 16 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

27

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2024 Year 01 Month 16 Day

Date of IRB

2023 Year 12 Month 25 Day

Anticipated trial start date

2024 Year 01 Month 16 Day

Last follow-up date

2024 Year 11 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2024 Year 01 Month 16 Day

Last modified on

2024 Year 07 Month 16 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000060905